LAVA Therapeutics's total assets for Q1 2025 were $71.16M, a decrease of -11.97% from the previous quarter. LVTX total liabilities were $45.37M for the fiscal quarter, a -14.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.